Former ProNAi CEO raises $2.7M for new startup that treats a rare hypercholesterolemia
Ann Arbor-area startup Gemphire Therapeutics just raised $2.7 million, according to a regulatory filing, for its drug that treats homozygous familial hypercholesterolemia. The drug candidate – called gemcabene – is being licensed from Pfizer, according to a December profile from Crain’s Detroit Business. The startup’s led by Mina Sooch, formerly CEO of Michigan’s ProNAi Therapeutics, which raised […]